Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

401 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum Albumin and Bleeding Events After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction (from the HAGAKURE-ACS Registry).
Yoshioka G, Natsuaki M, Goriki Y, Shinzato K, Nishihira K, Kuriyama N, Shimomura M, Inoue Y, Nishikido T, Hongo H, Kaneko T, Kamishita K, Yokoi K, Yajima A, Sakamoto Y, Tago M, Kawaguchi A, Yamaguchi T, Asaka M, Kotooka N, Sonoda S, Hikichi Y, Shibata Y, Node K. Yoshioka G, et al. Among authors: natsuaki m. Am J Cardiol. 2022 Feb 15;165:19-26. doi: 10.1016/j.amjcard.2021.10.043. Epub 2021 Dec 7. Am J Cardiol. 2022. PMID: 34893303
Comparison of long-term mortality after acute myocardial infarction treated by percutaneous coronary intervention in patients living alone versus not living alone at the time of hospitalization.
Nakatsuma K, Shiomi H, Watanabe H, Morimoto T, Taniguchi T, Toyota T, Furukawa Y, Nakagawa Y, Horie M, Kimura T; CREDO-Kyoto AMI Investigators. Nakatsuma K, et al. Am J Cardiol. 2014 Aug 15;114(4):522-7. doi: 10.1016/j.amjcard.2014.05.029. Epub 2014 Jun 6. Am J Cardiol. 2014. PMID: 24998090 Free article.
Acute effects of statin on reduction of angiopoietin-like 2 and glyceraldehyde-derived advanced glycation end-products levels in patients with acute myocardial infarction: a message from SAMIT (Statin for Acute Myocardial Infarction Trial).
Shimomura M, Oyama J, Takeuchi M, Shibata Y, Yamamoto Y, Kawasaki T, Komoda H, Kodama K, Sakuma M, Toyoda S, Inoue Y, Mine D, Natsuaki M, Komatsu A, Hikichi Y, Yamagishi S, Inoue T, Node K. Shimomura M, et al. Among authors: natsuaki m. Heart Vessels. 2016 Oct;31(10):1583-9. doi: 10.1007/s00380-015-0773-y. Epub 2015 Dec 23. Heart Vessels. 2016. PMID: 26699899 Clinical Trial.
Effect of Renal Dysfunction on the Risks for Ischemic and Bleeding Events in Patients With Atrial Fibrillation Receiving Percutaneous Coronary Intervention.
Yamamoto K, Shiomi H, Morimoto T, Natsuaki M, Takeji Y, Watanabe H, Yoshikawa Y, Matsumura-Nakano Y, Shizuta S, Tanabe K, Ando K, Kadota K, Morino Y, Kozuma K, Nakagawa Y, Kimura T. Yamamoto K, et al. Among authors: natsuaki m. Am J Cardiol. 2020 Feb 1;125(3):399-408. doi: 10.1016/j.amjcard.2019.10.049. Epub 2019 Nov 7. Am J Cardiol. 2020. PMID: 31771755
Periprocedural Stroke After Coronary Revascularization (from the CREDO-Kyoto PCI/CABG Registry Cohort-3).
Yamamoto K, Natsuaki M, Morimoto T, Shiomi H, Matsumura-Nakano Y, Nakatsuma K, Watanabe H, Yamamoto E, Kato E, Fuki M, Yamaji K, Nishikawa R, Nagao K, Takeji Y, Watanabe H, Tazaki J, Watanabe S, Saito N, Yamazaki K, Soga Y, Komiya T, Ando K, Minatoya K, Furukawa Y, Nakagawa Y, Kadota K, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-3 investigators. Yamamoto K, et al. Among authors: natsuaki m. Am J Cardiol. 2021 Mar 1;142:35-43. doi: 10.1016/j.amjcard.2020.11.031. Epub 2020 Dec 3. Am J Cardiol. 2021. PMID: 33279479
Drug-eluting stent thrombosis: current and future perspectives.
Kuramitsu S, Sonoda S, Ando K, Otake H, Natsuaki M, Anai R, Honda Y, Kadota K, Kobayashi Y, Kimura T. Kuramitsu S, et al. Among authors: natsuaki m. Cardiovasc Interv Ther. 2021 Apr;36(2):158-168. doi: 10.1007/s12928-021-00754-x. Epub 2021 Jan 13. Cardiovasc Interv Ther. 2021. PMID: 33439454 Review.
Comparison of Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting Among Patients With Three-Vessel Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From CREDO-Kyoto PCI/CABG Registry Cohort-3).
Matsumura-Nakano Y, Shiomi H, Morimoto T, Yamaji K, Ehara N, Sakamoto H, Takeji Y, Yoshikawa Y, Yamamoto K, Imada K, Tada T, Taniguchi R, Nishikawa R, Tada T, Uegaito T, Ogawa T, Yamada M, Takeda T, Eizawa H, Tamura N, Tambara K, Suwa S, Shirotani M, Tamura T, Inoko M, Nishizawa J, Natsuaki M, Sakai H, Yamamoto T, Kanemitsu N, Ohno N, Ishii K, Marui A, Tsuneyoshi H, Terai Y, Nakayama S, Yamazaki K, Takahashi M, Tamura T, Esaki J, Miki S, Onodera T, Mabuchi H, Furukawa Y, Tanaka M, Komiya T, Soga Y, Hanyu M, Ando K, Kadota K, Minatoya K, Nakagawa Y, Kimura T; On behalf the CREDO-Kyoto PCI/CABG Registry Cohort-3 Investigators. Matsumura-Nakano Y, et al. Among authors: natsuaki m. Am J Cardiol. 2021 Apr 15;145:25-36. doi: 10.1016/j.amjcard.2020.12.076. Epub 2021 Jan 14. Am J Cardiol. 2021. PMID: 33454340
401 results